Active, Not Recruiting
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
NCT05626855
- Conditions
- Anti-myostatin, Atrophy, Central Nervous System Diseases, +20 more
- Locations
-
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- UCSD Altman Clinical and Translational Research La Jolla, California, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Stanford Neuroscience Health Center Palo Alto, California, United States